Insider Trading & Ownership of Peter A. Thompson

Location: Hayward, CA
Summary: The estimated net worth of Peter A. Thompson is at least $199M dollars as of November 26, 2025. Peter A. Thompson is the Director of Sionna Therapeutics, Inc. and owns shares of Sionna Therapeutics, Inc. (SION) stock worth about $160M. Peter A. Thompson is the Director, 10%+ Owner of Corvus Pharmaceuticals, Inc. and owns shares of Corvus Pharmaceuticals, Inc. (CRVS) stock worth about $29.8M. Peter A. Thompson is the Director, 10%+ Owner of Edgewise Therapeutics, Inc. and owns shares of Edgewise Therapeutics, Inc. (EWTX) stock worth about $8.93M.
Signature: /s/ Peter A. Thompson
All Insider Reports: All Insider Reports

Notify me when Peter A. Thompson files a new Insider Trading report.

Ownership of Peter A. Thompson

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SION	Sionna Therapeutics, Inc.	Director	$160M	-$4.81M	-2.92%	Nov 24, 2025
CRVS	Corvus Pharmaceuticals, Inc.	Director, 10%+ Owner	$29.8M	-$4.89M	-14.1%	Jun 27, 2025
EWTX	Edgewise Therapeutics, Inc.	Director, 10%+ Owner	$8.93M	+$10M		Jun 16, 2025
ALPN	ALPINE IMMUNE SCIENCES, INC.	Director	$0			May 18, 2024
SPRY	ARS Pharmaceuticals, Inc.	Director	$0			Jun 25, 2025
DBTX	Decibel Therapeutics, Inc.	Director, 10%+ Owner				Jun 17, 2022
JANX	Janux Therapeutics, Inc.	Director				Jun 14, 2022
PMVP	PMV Pharmaceuticals, Inc.	Director, 10%+ Owner				Jun 2, 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.